Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- The Global Impact Factor (GIF)
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Matsuda Hirai
Department of Pharmacokinetics, Kyoto Pharmaceutical University, Kyoto, Japan
Biography
Matsuda Hirai is a researcher in the field of biomedical sciences, specifically focusing on glycobiology and its implications in various diseases. He has contributed significantly to understanding glycan structures and their roles in human diseases such as cancer and liver fibrosis. Hirai is affiliated with several academic institutions, including the National Institute of Advanced Industrial Science and Technology (AIST) in Japan, where his work on glycosylation has influenced the development of biomarkers for disease detection and therapeutic targets.
His research has focused on how alterations in glycosylation patterns in proteins and lipids can influence the progression of diseases such as cancer, particularly in how cancer cells interact with their environments. He has also been involved in identifying novel glycan-based biomarkers for liver disease and cancer, such as those associated with triple-negative breast cancer.
Publications
-
Commentary Article
Revolutionizing Drug Development with AI, Blockchain, and Genomics
Author(s): Matsuda Hirai*